There comes a moment in every child’s life when they begin to discover that, although their parents may seem to have all the answers, adults in general do ...
Clinical laboratory lobbying groups are suing the FDA over its plans to more strictly regulate lab-developed tests. For now, ...
Interesting Engineering on MSN4d
FDA calls Neuralink’s Blindsight a ‘breakthrough’ as Musk eyes vision for blindNonetheless, although the news has sparked much enthusiasm, what Blindsight is capable of—particularly in terms of regaining ...
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
After pushing back the decision date for Applied Therapeutics’ metabolic disorder drug govorestat, the FDA has now decided ...
The FDA should be more open and collaborative to unleash a surge in approvals of rare disease drugs, according to a report by ...
The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain ...
Sarfaraz K. Niazi, PhD, explains the FDA's new guidelines on post-approval changes for biosimilars, emphasizing the processes ...
Three consecutive commercial-scale batches successfully producedMajor milestone for potential BLA filing of sozinibercept in wet AMDProgress ...
The U.S. Food and Drug Administration has approved the sleep apnea feature ... It is typically an expensive process not ...
The type 2 diabetes drug metformin helped slow aging across multiple organs, including the brain, kidneys, and the skin, a ...
The Brighterside of News on MSN2d
Common diabetes drug found to significantly slow down agingScientists from the Chinese Academy of Sciences (CAS) have made a groundbreaking discovery about aging, raising the question: ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback